Noah Davis on October 28, 2026 12:48 pm Silver leverage is strong here; beta cuts both ways though. Reply
Emma Davis on October 28, 2026 12:48 pm I like the balance sheet here—less leverage than peers. Reply
Amelia Smith on October 28, 2026 12:49 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Patricia Johnson on October 28, 2026 12:50 pm Interesting update on Human Biologist Shares 5 Biohacks to Transform Your Health. Curious how the grades will trend next quarter. Reply
Olivia Jackson on October 28, 2026 12:52 pm Exploration results look promising, but permitting will be the key risk. Reply
Ava Rodriguez on October 28, 2026 12:52 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Robert Jones on October 28, 2026 12:53 pm Interesting update on Human Biologist Shares 5 Biohacks to Transform Your Health. Curious how the grades will trend next quarter. Reply
Oliver Lopez on October 28, 2026 12:54 pm I like the balance sheet here—less leverage than peers. Reply
Ava Rodriguez on October 28, 2026 12:55 pm Production mix shifting toward Videos might help margins if metals stay firm. Reply
Isabella Z. Jackson on October 28, 2026 12:56 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
John Williams on October 28, 2026 12:57 pm If AISC keeps dropping, this becomes investable for me. Reply
John Miller on October 28, 2026 12:58 pm I like the balance sheet here—less leverage than peers. Reply
Oliver Taylor on October 28, 2026 1:00 pm Nice to see insider buying—usually a good signal in this space. Reply
Jennifer Thompson on October 28, 2026 1:00 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Jennifer Brown on October 28, 2026 1:01 pm If AISC keeps dropping, this becomes investable for me. Reply
William Thomas on October 28, 2026 1:01 pm Exploration results look promising, but permitting will be the key risk. Reply
William U. Hernandez on October 28, 2026 1:02 pm Interesting update on Human Biologist Shares 5 Biohacks to Transform Your Health. Curious how the grades will trend next quarter. Reply
Emma Jackson on October 28, 2026 1:02 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Michael Martinez on October 28, 2026 1:03 pm If AISC keeps dropping, this becomes investable for me. Reply
James Brown on October 28, 2026 1:03 pm Exploration results look promising, but permitting will be the key risk. Reply
38 Comments
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Human Biologist Shares 5 Biohacks to Transform Your Health. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Interesting update on Human Biologist Shares 5 Biohacks to Transform Your Health. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
If AISC keeps dropping, this becomes investable for me.
Exploration results look promising, but permitting will be the key risk.
Interesting update on Human Biologist Shares 5 Biohacks to Transform Your Health. Curious how the grades will trend next quarter.
Uranium names keep pushing higher—supply still tight into 2026.
If AISC keeps dropping, this becomes investable for me.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.